Ibutilide for pharmacological cardioversion of atrial fibrillation and flutter: impact of race on efficacy and safety.

American journal of therapeutics

Volumn 10, Issue 4, 2003, Pages 259-263

  Gowda, Ramesh M ^a   Punukollu, Gopikrishna ^a   Khan, Ijaz A ^a   Wilbur, Sabrina L ^a   Vasavada, Balendu C ^a   Sacchi, Terrence J ^a  

^a LONG ISLAND COLLEGE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; IBUTILIDE; SULFONAMIDE;

ADULT; AGED; ARTICLE; CAUCASIAN; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; NEGRO; TORSADE DES POINTES;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIAL FLUTTER; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; SULFONAMIDES; TORSADES DE POINTES;

EID: 0142182444     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-200307000-00005     Document Type: Article

References (0)